| |
Migraine
|
|
| |
|
|
| |
|
|
|
|
|
my personal edition > migraine > news
E-Mail this DGReview to a colleague
DGReview
New Agonist, Almotriptan Effective for Migraine
A DGReview of :"Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial"
Cephalalgia
08/14/2002
By Harvey McConnell
The new, specific 5-HT1B/1D agonist almotriptan is an effective and well-tolerated treatment for migraine pain according to a new randomised, single-dose, double-blind study.
The multicentre trial compared almotriptan with sumatriptan among a cohort of 668 patients treated at Kings College Hospital, London, England; Hôpital Saint-Antoine-Service de Neurologie, Paris, France; and Hospital General de Valencia, Valencia, Spain.
Clinicians treated a single migraine attack of moderate or severe intensity in each patient with either oral almotriptan, at 12.5 mg and 25 mg, or sumatriptan 100 mg- the current standard treatment for migraine, or placebo. Primary efficacy was assessed of migraine pain relief, and with improvement from severe or moderate pain to mild or no pain, at two hours following treatment.
Clinicians calculated response rates among the patients, which were stratified for variation in baseline pain levels, and found both almotriptan doses were equivalent to sumatriptan and significantly better than placebo. In addition, other assessments they used of efficacy confirmed the equivalence of the almotriptan groups with the sumatriptan group.
Among the patients the overall incidence of adverse events showed that almotriptan at a dosage of 12.5 mg was as well tolerated as placebo (p=0.493), and significantly better tolerated than sumatriptan (p<0.001). There was no statistically significant difference in the incidence of adverse events between almotriptan 25 mg dosage and sumatriptan 100 mg dosage (p=0.376).
The results from this large clinical study indicate that the new, specific 5-HT1B/1D agonist, almotriptan, is an effective and well-tolerated treatment for migraine pain, the clinicians concluded.
Cephalalgia Volume 22 Issue 6 Page 453 - July 2002.
"Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial"
All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.
|
